On Saturday, May 31, 2014, ECEC and ICEC hosted the event, Women’s BMI as a factor in EC failure: An open discussion on the data available to date, at the Lisboa Congress Center in Lisbon, Portugal. The goal of this event was to present the data, facilitate a transparent information-sharing process, and engage in a scientific discussion. During the panel, which had approximately 250 people in attendance, representatives from Gedeon Richter, HRA Pharma, and the World Health Organization presented their respective analyses of the data they have available on this issue (see here for the event’s programme). In addition, and for those who were unable to attend the event, we hosted a webinar on Wednesday, June 4, which replicated the panel’s presentation.
In January 2014, the European Medicines Agency (EMA) began a review of emergency contraceptives in order to assess whether increased body weight and body mass index (BMI) reduce the efficacy of these medicines in preventing an unintended pregnancy following unprotected sexual intercourse or contraceptive failure. We are attentive to the EMA’s recommendations on this issue.